All Press Releases
PILA PHARMA AB, announces ink of agreement with pre-clinical service provider ERBC
Malmö, Sweden, 26 November 2021 PILA PHARMA AB (publ) announces that an agreement has been signed with the company ERBC, regarding the conduct of PILA PHARMA´s upcoming preclinical safety assessment studies. ERBC is a certified pre-clinical service provider, based in France and Italy. PILA PHARMA is, as previously announced, preparing a clinical phase 2b study of the anti-diabetic drug candidate…
PILA PHARMA AB skriver avtal med den prekliniska tjänstleveranören ERBC
Malmö, 26 november, 2021 PILA PHARMA AB (publ) meddelar att ett avtal har tecknats med företaget ERBC avseende genomförandet av PILA PHARMA:s kommande icke-kliniska toxikologiska studier. ERBC är en certifierad pre-klinisk tjänsteleverantör med säte i Frankrike och Italien. PILA PHARMA förbereder, som tidigare meddelats, en klinisk fas 2b-studie av läkemedelskandidaten XEN-D0501 mot diabetes typ 2. Tidigare har XEN-D0501 utvärderats i…
PHARMA AB – CEO Dorte X. Gram increases share holding
Malmö, Sweden, November 16, 2021 Download the press release as PDF here PILA PHARMA AB (publ) announces that CEO Dorte X. Gram on Monday, November 15, bought 31,570 shares in the company, after placing a bid for 45,000 shares. The shares was purchased at a price of SEK 6.50. The transaction took place through the company Gram Equity Invest, which…